What is GHK-Cu?
A naturally occurring tripeptide-copper complex — one of the most extensively studied molecules in tissue remodelling, gene expression modulation, and extracellular matrix research.
GHK-Cu (glycyl-L-histidyl-L-lysine copper peptide) is a tripeptide-copper complex composed of the amino acids glycine, histidine, and lysine bound to a copper(II) ion. The molecule occurs naturally in human plasma, saliva, and urine, and was first isolated and characterised by Dr Loren Pickart in 1973 during research into human plasma fractions that promoted hepatocyte survival and tissue repair.
In healthy adults, circulating GHK-Cu concentrations are approximately 200 ng/mL at age 20 but decline to roughly 80 ng/mL by age 60. This age-related decline in the copper peptide has become a focus of research into whether endogenous GHK-Cu levels play a role in maintaining tissue repair capacity, extracellular matrix integrity, and broader cellular homeostasis.
Mechanism of Action
How GHK-Cu Works
GHK-Cu binds copper(II) (Cu²⁺) with exceptionally high affinity, functioning as a physiological copper delivery system. This copper-binding capacity is central to its biological significance. Copper is a cofactor for several essential enzymes: lysyl oxidase, which catalyses the cross-linking of collagen and elastin fibres; superoxide dismutase (SOD), which provides antioxidant defence by neutralising superoxide radicals; and cytochrome c oxidase, a terminal enzyme in the mitochondrial electron transport chain required for aerobic energy production.
Beyond its role as a copper carrier, GHK-Cu directly modulates gene expression on a remarkably broad scale. Genome-wide microarray research has identified over 4,000 genes influenced by GHK, with particular concentration in pathways governing tissue repair, anti-inflammatory signalling, and extracellular matrix remodelling. The molecule stimulates the synthesis of collagen, glycosaminoglycans, and decorin — a proteoglycan involved in collagen fibril organisation — while downregulating matrix metalloproteinases that degrade the extracellular matrix.
GHK-Cu also modulates the TGF-β signalling pathway, which plays a central role in fibroblast activation and connective tissue deposition. These combined effects — copper delivery, direct gene expression modulation, and growth factor pathway regulation — position GHK-Cu as a multifunctional signalling molecule with broad relevance to dermatological and regenerative research.
Tissue Remodelling Research
Tissue Repair and Extracellular Matrix Research
GHK-Cu has been studied extensively in preclinical wound healing models, where research has demonstrated effects on multiple stages of the repair process. In skin regeneration studies, GHK-Cu promotes fibroblast migration and proliferation, stimulates angiogenesis (new blood vessel formation), and accelerates the re-epithelialisation of damaged tissue. The molecule's ability to modulate matrix metalloproteinases (MMPs) — the zinc-dependent enzymes that remodel the extracellular matrix — is a key mechanism studied in these models.
In dermal tissue models, studies have examined GHK-Cu's effects on skin elasticity and thickness. Research has shown that the copper peptide stimulates the production of both collagen and elastin, the structural proteins responsible for skin integrity, while simultaneously promoting the organised deposition of these fibres within the dermal extracellular matrix.
GHK-Cu has also been investigated for its effects on dermal papilla cell activity and extracellular matrix dynamics in tissue culture models. These findings have generated sustained research interest in tissue remodelling and regenerative biology.
Anti-Ageing and Cellular Decline
Age-Related Changes and GHK-Cu Levels
The age-related decline in circulating GHK-Cu levels correlates with well-documented reductions in tissue repair capacity, skin elasticity, and wound healing efficiency. Research has investigated whether this decline represents a contributing factor to — rather than merely a consequence of — age-related cellular deterioration. The observation that exogenous GHK-Cu can modulate gene expression patterns in aged cells toward profiles more characteristic of younger tissue has become a central focus of this research area.
Studies have explored whether restoring GHK-Cu levels in aged tissue models can modulate changes in skin elasticity, wound healing kinetics, and extracellular matrix composition. Research in these models has examined the peptide's effects on antioxidant enzyme activity — particularly superoxide dismutase — given the established role of oxidative stress in age-related tissue decline. GHK-Cu's capacity to bind and deliver copper to antioxidant defence pathways positions it as a candidate molecule for investigating the copper-dependent components of cellular ageing.
Ongoing research continues to examine the precise relationship between GHK-Cu, gene expression changes in ageing tissue, and the restoration of regenerative capacity. The breadth of genes influenced by this relatively small tripeptide — spanning inflammatory regulation, antioxidant defence, extracellular matrix organisation, and cellular proliferation — makes it a uniquely versatile tool in anti-ageing and cellular decline research.
All products are research compounds intended for laboratory research use only. Not for human or veterinary use. Kinetic Labs does not provide dosing guidance, therapeutic recommendations, or medical advice of any kind.